|
PRI - Pharmaceutical Research Institute in
Warsaw, Poland, is an R&D organization, which manufactures medicinal products and active pharmaceutical
ingredients (APIs), performs bioavailability and bioequivalence studies in a certified laboratory as well as conducts
research on the development of new technologies. Our medicinal products and active pharmaceutical ingredients are
manufactured, assayed and distributed according to the Pharmaceutical Law and the Good Practices.
The aim of the applied Quality Assurance System is to ensure that:
- The quality of the manufactured medicinal products meets the requirements set in the course of obtaining marketing
authorization and manufacturing license; the manufactured products are safe, therapeutically efficient and guarantee
patient safety.
- The quality of the manufactured active pharmaceutical ingredients (APIs) meets corresponding specifications and
Pharmacopoeia monographs.
- The manufacturing process is stable and meets the approved technological documentation requirements.
Our Quality Policy is realized by:
- The employment of highly educated and continuously trained staff.
- Constant improvement of our services by permanent monitoring of the processes and research activities as well as
the use of modern technological and analytical equipment.
Aware of our responsibility, together with
the staff we create our Quality Policy with the aim of building a fully professional and reliable company. My goal
is to constantly improve our products, services and all of the Quality System.
Wieslaw Szelejewski, Ph.D.
Director of the Pharmaceutical Research Institute
Warsaw, 18 Jan. 2006
|
0.1 MB